Scarica l'app Stockscreener
0.00
100.00%
-11.13
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché VERV Giù?
Forum
Previsione
Precedente Chiudi:
$11.13
Aprire:
$0
Volume 24 ore:
0
Relative Volume:
0.00
Capitalizzazione di mercato:
$994.04M
Reddito:
$20.65M
Utile/perdita netta:
$-192.65M
Rapporto P/E:
0.00
EPS:
-2.59
Flusso di cassa netto:
$-134.39M
1 W Prestazione:
-100.00%
1M Prestazione:
-100.00%
6M Prestazione:
-100.00%
1 anno Prestazione:
-100.00%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$0.00
$0.00
Portata 52W:
$0.00
$11.40
Verve Therapeutics Inc Stock (VERV) Company Profile
Nome
Verve Therapeutics Inc
Settore
Industria
Telefono
(978) 501-3026
Indirizzo
201 BROOKLINE AVENUE, BOSTON
Confronta VERV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VERV
Verve Therapeutics Inc
|
0.00 | 994.04M | 20.65M | -192.65M | -134.39M | -2.59 |
|
VRTX
Vertex Pharmaceuticals Inc
|
450.12 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
750.36 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
841.37 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
395.38 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
198.32 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Verve Therapeutics Inc Stock (VERV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-15 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2024-04-08 | Iniziato | H.C. Wainwright | Buy |
| 2023-04-13 | Iniziato | Canaccord Genuity | Buy |
| 2023-02-01 | Iniziato | Cantor Fitzgerald | Neutral |
| 2022-12-15 | Iniziato | Goldman | Sell |
| 2022-10-06 | Iniziato | Credit Suisse | Neutral |
| 2022-08-25 | Aggiornamento | Stifel | Hold → Buy |
| 2022-06-17 | Iniziato | BMO Capital Markets | Outperform |
| 2022-02-18 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-09-24 | Iniziato | Stifel | Hold |
| 2021-07-12 | Iniziato | Guggenheim | Buy |
| 2021-07-12 | Iniziato | JP Morgan | Neutral |
| 2021-07-12 | Iniziato | Jefferies | Buy |
| 2021-07-12 | Iniziato | William Blair | Outperform |
Mostra tutto
Verve Therapeutics Inc Borsa (VERV) Ultime notizie
Is Verve Therapeutics Inc. stock a safe haven asset2025 Geopolitical Influence & Expert-Curated Trade Recommendations - Newser
Will Verve Therapeutics Inc. stock maintain dividend yieldPortfolio Value Report & Real-Time Volume Analysis Alerts - Newser
Will Verve Therapeutics Inc. stock deliver shareholder valueJuly 2025 Reactions & Free Growth Oriented Trading Recommendations - Newser
Will Verve Therapeutics Inc. stock deliver consistent dividendsEarnings Trend Report & Safe Capital Growth Trade Ideas - Newser
Is Verve Therapeutics Inc. stock positioned for digital transformationDividend Hike & Target Return Focused Picks - BỘ NỘI VỤ
Aug Gainers: Can Verve Therapeutics Inc. stock beat analyst upgradesJuly 2025 Patterns & AI Forecasted Entry and Exit Points - moha.gov.vn
Is Verve Therapeutics Inc. stock a bargain at current levels2025 Momentum Check & Fast Gaining Stock Reports - BỘ NỘI VỤ
Can Verve Therapeutics Inc. stock attract ESG capital inflows2025 Volatility Report & Safe Swing Trade Setup Alerts - BỘ NỘI VỤ
Verve Therapeutics Inc Stock Analysis and ForecastMoving Average Strategies & Unlock Free Weekly Portfolio Checkups - earlytimes.in
What insider trading reveals about Verve Therapeutics Inc. stockMarket Trend Report & Stock Portfolio Risk Control - newser.com
Price momentum metrics for Verve Therapeutics Inc. explained2025 Support & Resistance & Technical Confirmation Trade Alerts - newser.com
Is Verve Therapeutics Inc. stock in correction or buying zoneRate Hike & Entry Point Strategy Guides - newser.com
How resilient is Verve Therapeutics Inc. stock in market downturnsWeekly Stock Analysis & AI Enhanced Market Trend Forecasts - newser.com
What drives Verve Therapeutics Inc stock pricePrice-to-Earnings Ratio Insights & Rapid Profit Portfolio - earlytimes.in
Automated trading signals detected on Verve Therapeutics Inc.July 2025 Breakouts & Reliable Trade Execution Plans - newser.com
Can Verve Therapeutics Inc. stock withstand economic slowdownWeekly Investment Report & Fast Moving Trade Plans - newser.com
Verve Therapeutics Inc. stock daily chart insightsQuarterly Trade Report & Growth Focused Entry Reports - newser.com
Sector ETF performance correlation with Verve Therapeutics Inc.Rate Cut & Risk Adjusted Buy/Sell Alerts - newser.com
Is Verve Therapeutics Inc. stock entering bullish territoryWeekly Market Outlook & Daily Price Action Insights - newser.com
Is Verve Therapeutics Inc. stock a safe buy before earningsProduct Launch & Verified High Yield Trade Plans - newser.com
How to track smart money flows in Verve Therapeutics Inc.Earnings Overview Summary & Safe Entry Point Identification - newser.com
Will Verve Therapeutics Inc. stock continue dividend increases2025 EndofYear Setup & Risk Managed Investment Entry Signals - Fundação Cultural do Pará
Technical analysis overview for Verve Therapeutics Inc. stockEarnings Recap Summary & AI Driven Stock Movement Reports - newser.com
Has Verve Therapeutics Inc. formed a bullish divergenceGap Up & Entry Point Strategy Guides - newser.com
Will Verve Therapeutics Inc. bounce back from current supportTrade Signal Summary & Safe Capital Allocation Plans - newser.com
Verve Therapeutics Inc Azioni (VERV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.56%
1.23%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):